Keyphrases
Spinocerebellar Ataxia
100%
Ataxia
100%
Blood Biomarkers
100%
Clinical Biomarkers
100%
Early Disease
100%
Spinocerebellar Ataxia Type 3 (SCA3)
100%
Pathologic
26%
ATXN1
20%
ATXN3
20%
Ataxic
13%
Plasma Neurofilament Light Chain
13%
Cognitive Impairment
6%
Clinical Manifestations
6%
Prospective Longitudinal Study
6%
Motor Signs
6%
Brainstem
6%
Longitudinal Observational Study
6%
Imaging Marker
6%
Therapeutic Intervention
6%
Biological Markers
6%
Corticospinal Tract
6%
Harmonized Data
6%
Diplopia
6%
Disease Stage
6%
Neuropsychological Tests
6%
Depression Score
6%
Age Control
6%
Preclinical Imaging
6%
Fatigue Index
6%
Referral Center
6%
Chain Level
6%
Neurofilament Light (NF-L)
6%
Urinary Dysfunction
6%
Functional Scale
6%
Multinational Network
6%
Swallowing Difficulties
6%
Extrapyramidal Signs
6%
Lower Motor Neuron Signs
6%
Sensory Ataxia
6%
Pharmacology, Toxicology and Pharmaceutical Science
Spinocerebellar Degeneration
100%
Biological Marker
100%
Disease
100%
Ataxia
100%
Observational Study
6%
Cognitive Defect
6%
Extrapyramidal Symptoms
6%
Urinary Dysfunction
6%
Diplopia
6%
Biochemistry, Genetics and Molecular Biology
Light Chain
100%
Neurofilament Light
100%
Blood Plasma
66%
Observational Study
33%
Lower Motor Neuron
33%
Neuroscience
Spinocerebellar Ataxia
100%
Ataxia
100%
Neurofilament Light Chain
18%
Blood Plasma
12%
Cognitive Disorders
6%
Brainstem
6%
Lower Motor Neuron
6%
Diplopia
6%
Extrapyramidal Symptoms
6%